| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/16/2011 | CN101972240A Modafinil Composition |
| 02/16/2011 | CN101972234A 莫达非尼分散片及其制备方法 Modafinil tablet and its preparation method |
| 02/16/2011 | CN101972224A Eye in-situ gel |
| 02/16/2011 | CN101972091A Biological clock nerve-soothing hypnosis medicinal pillow |
| 02/16/2011 | CN101700304B Method for detecting circulation plus decoction oral liquid |
| 02/16/2011 | CN101623254B Gastrodin injection and preparation method thereof |
| 02/16/2011 | CN101619054B New coumarin active content, preparation method and application thereof |
| 02/16/2011 | CN101601655B Maleic acid cinepazide liposome injection and new application thereof |
| 02/16/2011 | CN101306103B Medicine composition containing morinda root oligosacchride and its preparation method |
| 02/16/2011 | CN101238106B Fluoro substituted 2-oxo azepan derivatives |
| 02/16/2011 | CN101194903B Dropping pills containing Isocarboxazid and method for preparing the same |
| 02/16/2011 | CN101184729B Inhibitors of cytosolic phospholipase a2 |
| 02/16/2011 | CN101156713B A tobacco for give up smoking |
| 02/16/2011 | CN101100416B Small molecule inhibitor for preventing Alzheimer's disease Abeta polypeptide from fiberizing and its preparation method, pharmaceutical composition and application |
| 02/16/2011 | CN101032560B Chinese medicine composition for treating somnipathy and preparing method thereof |
| 02/16/2011 | CN101032474B Rasagiline transparent patch for curing and preventing neurological diseases and the preparing method thereof |
| 02/15/2011 | US7888391 Method for reducing the severity of neurological disorders |
| 02/15/2011 | US7888358 Serotonine, dopamine and norendrenaline receptors; antidepressants, anxiolytic agents, eating disorders; obesity; bipolar; drug abuse; neurodegenerative diseases |
| 02/15/2011 | US7888347 Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists |
| 02/15/2011 | US7888342 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 02/15/2011 | US7888291 Substrates and assays for β-secretase |
| 02/15/2011 | US7888076 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | US7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/15/2011 | US7887807 Anti-IL-12 antibodies and compositions |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/15/2011 | CA2615271C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 02/15/2011 | CA2592986C Heteroaromatic quinoline compounds |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2480560C .kappa.-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2465043C Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 02/15/2011 | CA2461348C [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 02/15/2011 | CA2456411C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/15/2011 | CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 02/15/2011 | CA2450890C Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram |
| 02/15/2011 | CA2450213C Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2433535C Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2377085C Substituted benzimidazoles |
| 02/15/2011 | CA2352765C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2286397C Humanized antibodies and methods for forming humanized antibodies |
| 02/10/2011 | WO2011017634A2 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 02/10/2011 | WO2011017600A2 Compositions and methods for treating beta-amyloid related diseases |
| 02/10/2011 | WO2011017404A2 Retroelements and mental disorders and methods of measuring l1 retrotransposition |
| 02/10/2011 | WO2011017319A1 Methods of treating disorders associated with protein polymerization |
| 02/10/2011 | WO2011017299A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
| 02/10/2011 | WO2011017132A2 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 02/10/2011 | WO2011016568A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016567A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016559A1 Heterocyclic compound and use thereof |
| 02/10/2011 | WO2011016504A1 Nitrogenous-ring acylguanidine derivative |
| 02/10/2011 | WO2011016501A1 Prophylactic or therapeutic agent for cancer |
| 02/10/2011 | WO2011016468A1 Benzyl piperidine compound |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011016239A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016238A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016234A1 Picolinamide derivatives as ttx-s blockers |
| 02/10/2011 | WO2011015572A1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 02/10/2011 | WO2011015537A1 Co-therapy for the treatment of epilepsy and related disorders |
| 02/10/2011 | WO2011015428A1 Use of xenon for treating hypersensitivity to pain |
| 02/10/2011 | WO2011015360A1 Pharmaceutical compounds of o-desmethyl-tramadol and cox-inhibitors |
| 02/10/2011 | WO2011015349A2 Methods for enhancing the cognitive function |
| 02/10/2011 | WO2011015343A1 Metabotropic glutamate receptor modulators |
| 02/10/2011 | WO2011015241A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/10/2011 | WO2011014973A2 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/10/2011 | WO2011014925A1 Process for obtaining peptide fractions |
| 02/10/2011 | WO2010148121A3 Benzothiazole derivatives |
| 02/10/2011 | WO2010138024A3 Agent for protecting brain cells |
| 02/10/2011 | WO2010008776A9 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110035232 Methods of treating hepatic encephalopathy |
| 02/10/2011 | US20110034568 Compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 02/10/2011 | US20110034566 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 02/10/2011 | US20110034565 Psycho-pharmaceuticals |
| 02/10/2011 | US20110034564 Soluble complexes of curcumin |
| 02/10/2011 | US20110034563 Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect |
| 02/10/2011 | US20110034562 Psycho-pharmaceuticals |
| 02/10/2011 | US20110034553 Novel conjugates for treating neurodegenerative diseases and disorders |
| 02/10/2011 | US20110034551 Methods of increasing sarcosine levels for treating schizophrenia |
| 02/10/2011 | US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 02/10/2011 | US20110034542 Novel synthetic analogs of sphingolipids |
| 02/10/2011 | US20110034540 Use of the CYP46A1 Gene for the Treatment of Alzheimer's Disease |
| 02/10/2011 | US20110034534 siRNA compounds and methods of use thereof |
| 02/10/2011 | US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2011 | US20110034526 Benzimidazole Compounds |
| 02/10/2011 | US20110034525 Nonsedating alpha-2 agonists |
| 02/10/2011 | US20110034523 Crystalline forms of rufinamide |
| 02/10/2011 | US20110034517 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/10/2011 | US20110034516 Aminopyrazole derivatives |
| 02/10/2011 | US20110034515 Indole modulators of the alpha 7 nicotinic acetylcholine receptor |
| 02/10/2011 | US20110034513 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production |